NCT01890005

Low Dose Aspirin for the Prevention of Preeclampsia

Low Dose Aspirin Between 13 and 16 Weeks of Pregnancy for the Prevention of Preeclampsia. Double Blind, Randomized, Controlled Trial.

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 476 (estimated)
• Sponsor: Saint Thomas Hospital, Panama · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

Preeclampsia is one of the three leading causes of maternal morbidity and mortality all over the world. The use of low dose aspirin has been mentioned in several studies with promising results. The investigators decided to evaluate the use of low dose aspirin, starting between 13 and 16 weeks of pregnancy, based on clinical characteristics only to reduce the incidence of preeclampsia.

Conditions

• Preeclampsia

Interventions

Type	Name	Description
DRUG	Aspirin	Low dose aspirin (100 mg) starting between 13 and 16 weeks of pregnancy until 36 weeks of pregnancy, taken at night.
DRUG	Placebo	Placebo starting between 13 and 16 weeks of pregnancy until 36 weeks of pregnancy, taken at night.

Timeline

• Start date: 2013-07-01
• Primary completion: 2013-12-01
• Completion: 2014-01-01
• First posted: 2013-07-01
• Last updated: 2013-07-01

Locations

1 site across 1 country: Panama